- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05007730
Enhancing Health and Quality of Life for Individuals With Dementia Through Transitional-State Snacks
Malnutrition significantly contributes to the disability and mortality associated with Alzheimer's disease and Alzheimer's disease-related dementias. Thus, nutritional status is one important, modifiable clinical factor for maintaining physical and cognitive health among persons with dementia (PWD). This project will pilot an innovative approach to enhancing nutrition through the use of transitional-state snack supplements, or foods that start as one texture and change to another.
Specifically, this study aims to demonstrate the feasibility, acceptability, and safety of a transitional-state therapeutic nutrition supplement among adults with dementia. The central hypothesis is that access to ready-made, savory, nutrient- dense snack supplements that resemble "typical" preferred foods and eating habits will result in improved nutritional intake and status among PWD.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Oregon
-
Eugene, Oregon, United States, 97403
- University of Oregon
-
Portland, Oregon, United States, 97239
- Oregon Health & Science University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Medically stable
- Community dwelling
- Has a medical diagnosis of dementia or possible dementia
Exclusion Criteria:
- Does not live at home
- Cannot participate in the protocol independently and do not have a consistent caregiver who can provide assistance
- Does not have smartphone access
- Requires 100% feeding assistance
- Is NPO (nil per os)
- Has multiple food allergies
- Requires a strict renal, low-fat, and/or no-salt diet
- Is deemed unsafe for the transitional-state foods by a speech-language pathologist
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Arm
|
Participants will consume at least one "snack-sized" package of the transitional-state food supplements per day across the intervention trial.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant enrollment rates (%)
Time Frame: Measured during recruitment (at baseline, prior to study onset; week 0)
|
The percentage of participants enrolled (i.e., who meet all eligibility criteria) as compared to the total number of participants who are recruited (i.e., initiate contact with the research team)
|
Measured during recruitment (at baseline, prior to study onset; week 0)
|
|
Proportion of participants deemed eligible to consume transitional-state foods
Time Frame: Prior to enrollment (to determine eligibility at baseline, prior to study onset; week 0)
|
Instrumental swallowing assessments will be conducted for each participant by a licensed speech-language pathologist to determine whether the potential participant can safely consume transitional-state foods based on their swallowing physiology.
The number of potential participants deemed eligible to consume this consistency of food will be compared to the total number of potential participants receiving the swallow study.
|
Prior to enrollment (to determine eligibility at baseline, prior to study onset; week 0)
|
|
Participant retention rates (%)
Time Frame: Measured at the end of the study (post-intervention, after 8 weeks of snack consumption)
|
The percentage of participants retained (i.e., who who remain enrolled and participate for the duration of the study) as compared to the total number of participants who are enrolled
|
Measured at the end of the study (post-intervention, after 8 weeks of snack consumption)
|
|
Change in acceptability of nutrition supplements
Time Frame: Measured weekly for enrolled participants (weeks 1, 2, 3, 4, 5, 6, 7, 8)
|
Using a Likert (5 point) rating scale, participants will rate their acceptability of the nutrition supplements each week.
Change in acceptability will be calculated over the length of the study (e.g., increased or decreased acceptability over time)
|
Measured weekly for enrolled participants (weeks 1, 2, 3, 4, 5, 6, 7, 8)
|
|
Number of test snacks consumed each week
Time Frame: Measured weekly for enrolled participants (weeks 1, 2, 3, 4, 5, 6, 7, 8)
|
As a measured of adherence to the protocol, participants will document the total number of test snacks consumed each week (protocol is for at least one snack per day)
|
Measured weekly for enrolled participants (weeks 1, 2, 3, 4, 5, 6, 7, 8)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in malnutrition status (not present, present, moderate, severe)
Time Frame: Measured at baseline (study onset) and post-intervention (end of study after 8 weeks of snack consumption)
|
Malnutrition status (not present, present, moderate, severe) will be assessed via a nutrition-focused physical exam (NFPE) by a registered dietitian.
The exams will be guided by the recommendations of the American Society for Parenteral and Enteral Nutrition (ASPEN) in conjunction with the Academy of Nutrition and Dietetics (AND) and use the following characteristics for diagnosing malnutrition: insufficient energy intake, weight loss, loss of muscle mass, loss of subcutaneous fat, fluid accumulation, and diminished functional status.
Using published definitions of the six clinical characteristics, a diagnosis of severe malnutrition, moderate malnutrition, or not malnourished will be made.
|
Measured at baseline (study onset) and post-intervention (end of study after 8 weeks of snack consumption)
|
|
Change in malnutrition risk score
Time Frame: Measured at baseline (study onset) and post-intervention (end of study after 8 weeks of snack consumption)
|
A malnutrition risk score will be calculated using the Mini Nutritional Assessment-Short Form (MNA-SF).
Using the information collected by a registered dietitian during a nutrition-focused physical exam, the MNA-SF will be scored; the MNA-SF is a six-item, validated, and reliable screening tool for malnutrition risk.
|
Measured at baseline (study onset) and post-intervention (end of study after 8 weeks of snack consumption)
|
|
Change in daily energy intake (kcal/d)
Time Frame: Baseline (study onset), mid-intervention (approximately 4 weeks into the trial), post-intervention (end of study after 8 weeks of snack consumption)
|
Daily energy intake (in kcal/d) will be calculated based on photo-assisted, 24-hour dietary recalls completed via telephone.
Three recalls will take place over the course of 2 weeks for each time point of interest.
|
Baseline (study onset), mid-intervention (approximately 4 weeks into the trial), post-intervention (end of study after 8 weeks of snack consumption)
|
|
Change in fat intake (g/d)
Time Frame: Baseline (study onset), mid-intervention (approximately 4 weeks into the trial), post-intervention (end of study after 8 weeks of snack consumption)
|
Daily fat intake (in g/d) will be calculated based on photo-assisted, 24-hour dietary recalls completed via telephone.
Three recalls will take place over the course of 2 weeks for each time point of interest.
|
Baseline (study onset), mid-intervention (approximately 4 weeks into the trial), post-intervention (end of study after 8 weeks of snack consumption)
|
|
Change in protein intake (g/d)
Time Frame: Baseline (study onset), mid-intervention (approximately 4 weeks into the trial), post-intervention (end of study after 8 weeks of snack consumption)
|
Daily protein intake (in g/d) will be calculated based on photo-assisted, 24-hour dietary recalls completed via telephone.
Three recalls will take place over the course of 2 weeks for each time point of interest.
|
Baseline (study onset), mid-intervention (approximately 4 weeks into the trial), post-intervention (end of study after 8 weeks of snack consumption)
|
|
Change in carbohydrate intake (g/d)
Time Frame: Baseline (study onset), mid-intervention (approximately 4 weeks into the trial), post-intervention (end of study after 8 weeks of snack consumption)
|
Daily carbohydrate intake (in g/d) will be calculated based on photo-assisted, 24-hour dietary recalls completed via telephone.
Three recalls will take place over the course of 2 weeks for each time point of interest.
|
Baseline (study onset), mid-intervention (approximately 4 weeks into the trial), post-intervention (end of study after 8 weeks of snack consumption)
|
|
Change in calcium intake (mg/d)
Time Frame: Baseline (study onset), mid-intervention (approximately 4 weeks into the trial), post-intervention (end of study after 8 weeks of snack consumption)
|
Daily calcium intake (in mg/d) will be calculated based on photo-assisted, 24-hour dietary recalls completed via telephone.
Three recalls will take place over the course of 2 weeks for each time point of interest.
|
Baseline (study onset), mid-intervention (approximately 4 weeks into the trial), post-intervention (end of study after 8 weeks of snack consumption)
|
|
Change in vitamin D intake (mg/d)
Time Frame: Baseline (study onset), mid-intervention (approximately 4 weeks into the trial), post-intervention (end of study after 8 weeks of snack consumption)
|
Daily vitamin D intake (in mg/d) will be calculated based on photo-assisted, 24-hour dietary recalls completed via telephone.
Three recalls will take place over the course of 2 weeks for each time point of interest.
|
Baseline (study onset), mid-intervention (approximately 4 weeks into the trial), post-intervention (end of study after 8 weeks of snack consumption)
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 02042020.009
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
Benjamin Rose Institute on AgingNational Institute on Aging (NIA)RecruitingMild Dementia | Moderate DementiaUnited States
-
Yaolin PeiNational Institutes of Health (NIH)RecruitingEnd of Life Decision Making | Dementia Caregivers | Advanced DementiaUnited States
-
Benuvia Therapeutics Inc.MandaraNot yet recruiting
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityCompletedDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeActive, not recruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityCompletedDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
NYU Langone HealthRecruiting
-
The University of Hong KongNot yet recruiting
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
Clinical Trials on Transitional-state food therapeutic nutrition supplement
-
Société des Produits Nestlé (SPN)University of the East Ramon Magsaysay Memorial Medical Center, Inc, Philippines and other collaboratorsNot yet recruiting
-
Arafarma Group, S.A.Completed
-
Jonsson Comprehensive Cancer CenterKate Farms IncActive, not recruitingLocally Advanced Head and Neck CarcinomaUnited States
-
Able Biolabs, LLCActive, not recruitingMusculoskeletal Pain | Mobility Limitation | Joint DiscomfortUnited States
-
Able Biolabs, LLCCompletedMenopausal Symptoms | Microbiome | Perimenopause | Menopause-Related Quality of LifeUnited States
-
4Life Research, LLCCompleted
-
University of ExeterKingston UniversityCompletedSupplementation During Endurance PerformanceUnited Kingdom
-
Nag Food Supplement Trading LLCCitruslabsCompletedSkin Health | Hair Health | Joint HealthUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLocally Advanced Head and Neck CarcinomaUnited States
-
Arafarma Group, S.A.RecruitingEndometriosis (Diagnosis)Spain